Life Sciences Summit to Spotlight Investment Trends and Entrepreneurial Innovation in Utah

Utah's life sciences community will converge at the 2025 Entrepreneur & Investor (E&I) Life Sciences Summit, featuring keynote presentations from prominent industry leaders Monica DiCenso of J.P. Morgan and Earl "Eb" Bright from Stanford BioDesign.

The summit, sponsored by Wilson Sonsini and hosted by BioUtah and the University of Utah's Technology Licensing Office, will explore critical topics including investment landscapes, entrepreneurial challenges, and emerging technological innovations in life sciences.

Key highlights include a high-stakes pitch competition where life sciences companies will present groundbreaking innovations across medical devices, diagnostics, pharmaceuticals, and digital health sectors. Participants will compete for cash prizes and industry recognition, offering a platform for emerging entrepreneurs to showcase transformative technologies.

Distinguished panelists, including CEOs from Recursion, Nusano, Culmination Bio, and Owlet Baby Care, will discuss strategies for building successful life sciences companies. Venture capital experts from Epic Ventures, Stephens, Cross-Border Impact Ventures, and J.P. Morgan will provide insights into funding dynamics and investment opportunities.

The event's comprehensive programming includes specialized track sessions covering funding sources, entrepreneurial experiences, and legal considerations, providing attendees with comprehensive perspectives on the life sciences ecosystem.

DiCenso, who leads J.P. Morgan's global investment opportunities group, will share economic insights that have been featured on major financial platforms. Bright, with extensive experience in technology development and company formation, will offer perspectives on entrepreneurial challenges and opportunities.

The summit represents a critical networking and knowledge-sharing opportunity for professionals in Utah's rapidly evolving life sciences landscape, highlighting the state's growing significance in biotechnology and medical innovation.